Literature DB >> 28257929

Multifactorial causal model of brain (dis)organization and therapeutic intervention: Application to Alzheimer's disease.

Yasser Iturria-Medina1, Félix M Carbonell2, Roberto C Sotero3, Francois Chouinard-Decorte4, Alan C Evans4.   

Abstract

Generative models focused on multifactorial causal mechanisms in brain disorders are scarce and generally based on limited data. Despite the biological importance of the multiple interacting processes, their effects remain poorly characterized from an integrative analytic perspective. Here, we propose a spatiotemporal multifactorial causal model (MCM) of brain (dis)organization and therapeutic intervention that accounts for local causal interactions, effects propagation via physical brain networks, cognitive alterations, and identification of optimum therapeutic interventions. In this article, we focus on describing the model and applying it at the population-based level for studying late onset Alzheimer's disease (LOAD). By interrelating six different neuroimaging modalities and cognitive measurements, this model accurately predicts spatiotemporal alterations in brain amyloid-β (Aβ) burden, glucose metabolism, vascular flow, resting state functional activity, structural properties, and cognitive integrity. The results suggest that a vascular dysregulation may be the most-likely initial pathologic event leading to LOAD. Nevertheless, they also suggest that LOAD it is not caused by a unique dominant biological factor (e.g. vascular or Aβ) but by the complex interplay among multiple relevant direct interactions. Furthermore, using theoretical control analysis of the identified population-based multifactorial causal network, we show the crucial advantage of using combinatorial over single-target treatments, explain why one-target Aβ based therapies might fail to improve clinical outcomes, and propose an efficiency ranking of possible LOAD interventions. Although still requiring further validation at the individual level, this work presents the first analytic framework for dynamic multifactorial brain (dis)organization that may explain both the pathologic evolution of progressive neurological disorders and operationalize the influence of multiple interventional strategies.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Computational therapeutic design; Control theory of networks; Intra-brain pathological spreading; Multifactorial causal model; Multimodal direct interactions; Neurodegeneration; Triggering pathological event

Mesh:

Substances:

Year:  2017        PMID: 28257929     DOI: 10.1016/j.neuroimage.2017.02.058

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  40 in total

1.  Integrating molecular, histopathological, neuroimaging and clinical neuroscience data with NeuroPM-box.

Authors:  Yasser Iturria-Medina; Félix Carbonell; Atousa Assadi; Quadri Adewale; Ahmed F Khan; Tobias R Baumeister; Lazaro Sanchez-Rodriguez
Journal:  Commun Biol       Date:  2021-05-21

2.  Simulating the outcome of amyloid treatments in Alzheimer's disease from imaging and clinical data.

Authors:  Clément Abi Nader; Nicholas Ayache; Giovanni B Frisoni; Philippe Robert; Marco Lorenzi
Journal:  Brain Commun       Date:  2021-04-28

3.  A method for inferring regional origins of neurodegeneration.

Authors:  Justin Torok; Pedro D Maia; Fon Powell; Sneha Pandya; Ashish Raj
Journal:  Brain       Date:  2018-03-01       Impact factor: 13.501

4.  Blood and brain gene expression trajectories mirror neuropathology and clinical deterioration in neurodegeneration.

Authors:  Yasser Iturria-Medina; Ahmed F Khan; Quadri Adewale; Amir H Shirazi
Journal:  Brain       Date:  2020-02-01       Impact factor: 13.501

Review 5.  Preventing dementia by preventing stroke: The Berlin Manifesto.

Authors:  Vladimir Hachinski; Karl Einhäupl; Detlev Ganten; Suvarna Alladi; Carol Brayne; Blossom C M Stephan; Melanie D Sweeney; Berislav Zlokovic; Yasser Iturria-Medina; Costantino Iadecola; Nozomi Nishimura; Chris B Schaffer; Shawn N Whitehead; Sandra E Black; Leif Østergaard; Joanna Wardlaw; Steven Greenberg; Leif Friberg; Bo Norrving; Brian Rowe; Yves Joanette; Werner Hacke; Lewis Kuller; Martin Dichgans; Matthias Endres; Zaven S Khachaturian
Journal:  Alzheimers Dement       Date:  2019-07       Impact factor: 21.566

Review 6.  Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities.

Authors:  Judit M Perez Ortiz; Russell H Swerdlow
Journal:  Br J Pharmacol       Date:  2019-03-06       Impact factor: 8.739

7.  Fluid biomarker agreement and interrelation in dementia due to Alzheimer's disease.

Authors:  Panagiotis Alexopoulos; Jennifer Roesler; Lukas Werle; Nathalie Thierjung; Iliana Lentzari; Marion Ortner; Timo Grimmer; Nikolaos Laskaris; Antonios Politis; Philippos Gourzis; Alexander Kurz; Robert Perneczky
Journal:  J Neural Transm (Vienna)       Date:  2017-11-15       Impact factor: 3.575

Review 8.  From Maps to Multi-dimensional Network Mechanisms of Mental Disorders.

Authors:  Urs Braun; Axel Schaefer; Richard F Betzel; Heike Tost; Andreas Meyer-Lindenberg; Danielle S Bassett
Journal:  Neuron       Date:  2018-01-03       Impact factor: 17.173

Review 9.  Models of Network Spread and Network Degeneration in Brain Disorders.

Authors:  Ashish Raj; Fon Powell
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-08-03

10.  Multivariate MR biomarkers better predict cognitive dysfunction in mouse models of Alzheimer's disease.

Authors:  Alexandra Badea; Natalie A Delpratt; R J Anderson; Russell Dibb; Yi Qi; Hongjiang Wei; Chunlei Liu; William C Wetsel; Brian B Avants; Carol Colton
Journal:  Magn Reson Imaging       Date:  2019-03-30       Impact factor: 2.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.